MABVAX THERAPEUTICS HLDGS IN

CUSIP: 55414P504 Class: COM NEW

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 17,547 Value ($000) $12 Avg Close — Range —
Q3 2017
Shares 30,625 Value ($000) $20 Avg Close — Range —
Q2 2017
Shares 5,144 Value ($000) $7 Avg Close — Range —
Q1 2017
Shares 4,957 Value ($000) $11 Avg Close — Range —
Q3 2016
Shares 134 Value ($000) $1 Avg Close — Range —